These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [The future of inhaled antibiotic therapy. New products]. Vendrell Relat M; Muñoz Castro G; Sabater Talaverano G; De Gracia Roldán J Arch Bronconeumol; 2011 Jun; 47 Suppl 6():30-2. PubMed ID: 21703477 [TBL] [Abstract][Full Text] [Related]
8. Respiratory therapies in the critical care setting. Should aerosolized antibiotics be administered to prevent or treat ventilator-associated pneumonia in patients who do not have cystic fibrosis? MacIntyre NR; Rubin BK Respir Care; 2007 Apr; 52(4):416-21; discussion 421-2. PubMed ID: 17417976 [TBL] [Abstract][Full Text] [Related]
9. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis. Falagas ME; Kasiakou SK Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582 [TBL] [Abstract][Full Text] [Related]
11. Inhaled antimicrobial therapy: from cystic fibrosis to the flu. O'Riordan TG Respir Care; 2000 Jul; 45(7):836-45. PubMed ID: 10926381 [TBL] [Abstract][Full Text] [Related]
12. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study. Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758 [TBL] [Abstract][Full Text] [Related]
13. Consensus summary of aerosolized antimicrobial agents: application of guideline criteria. Insights from the Society of Infectious Diseases Pharmacists. Le J; Ashley ED; Neuhauser MM; Brown J; Gentry C; Klepser ME; Marr AM; Schiller D; Schwiesow JN; Tice S; VandenBussche HL; Wood GC; Pharmacotherapy; 2010 Jun; 30(6):562-84. PubMed ID: 20500046 [TBL] [Abstract][Full Text] [Related]
14. Administration of antimicrobials via the respiratory tract for the treatment of patients with nosocomial pneumonia: a meta-analysis. Ioannidou E; Siempos II; Falagas ME J Antimicrob Chemother; 2007 Dec; 60(6):1216-26. PubMed ID: 17934205 [TBL] [Abstract][Full Text] [Related]
15. Aerosolised antibiotics: a critical appraisal of their use. Hagerman JK; Hancock KE; Klepser ME Expert Opin Drug Deliv; 2006 Jan; 3(1):71-86. PubMed ID: 16370941 [TBL] [Abstract][Full Text] [Related]
17. Other therapeutic modalities and practices: implications for clinical trials of hospital-acquired or ventilator-associated pneumonia. Chastre J; Luyt CE Clin Infect Dis; 2010 Aug; 51 Suppl 1():S54-8. PubMed ID: 20597673 [TBL] [Abstract][Full Text] [Related]
18. Aerosolized antibiotics for ventilator-associated tracheobronchitis: let's go with the flow! Nseir S Crit Care Med; 2008 Jul; 36(7):2191-2. PubMed ID: 18594225 [No Abstract] [Full Text] [Related]
19. Nebulized tobramycin in patients with chronic respiratory infections during clinical evolution of Wegener's granulomatosis. Terzano C; Taurino AE; Peona V Eur Rev Med Pharmacol Sci; 2001; 5(4):131-8. PubMed ID: 12067081 [TBL] [Abstract][Full Text] [Related]
20. Aerosolized antibiotics: the past, present and future, with a special emphasis on inhaled colistin. Michalopoulos AS Expert Opin Drug Deliv; 2012 May; 9(5):493-5. PubMed ID: 22512595 [No Abstract] [Full Text] [Related] [Next] [New Search]